Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03989232
What this trial is testing

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 961
Early research (Phase 1)Study completedNCT03790787
What this trial is testing

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Who this might be right for
Patients
Hua Medicine Limited 16
Not applicableStudy completedNCT00701155
What this trial is testing

Observational Study to Evaluate the Safety While Using Levemir®

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,593
Post-approval studies (Phase 4)Study completedNCT01068652
What this trial is testing

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 403
Early research (Phase 1)Study completedNCT01432938
What this trial is testing

The Effect of Dulaglutide on the Action of Warfarin in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 28
Early research (Phase 1)Study completedNCT05579314
What this trial is testing

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sciwind Biosciences USA Co., Ltd. 127
Post-approval studies (Phase 4)Ended earlyNCT00799448
What this trial is testing

Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 40
Early research (Phase 1)Study completedNCT00833716
What this trial is testing

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Renal Impairment
Novo Nordisk A/S 62
Early research (Phase 1)Study completedNCT01524809
What this trial is testing

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 26
Large-scale testing (Phase 3)Ended earlyNCT00472953
What this trial is testing

Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 38
Large-scale testing (Phase 3)Study completedNCT03819153
What this trial is testing

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,533
Large-scale testing (Phase 3)Temporarily pausedNCT01257412
What this trial is testing

Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 375
Not applicableStudy completedNCT01900834
What this trial is testing

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 61
Not applicableWithdrawnNCT03355092
What this trial is testing

The vBlocT2D Study

Who this might be right for
Type2 DiabetesObesity
Kaiser Permanente
Not applicableStudy completedNCT04502212
What this trial is testing

Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM

Who this might be right for
Type 2 Diabetes
General Electric Research 16
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Early research (Phase 1)Study completedNCT00949091
What this trial is testing

Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 60
Early research (Phase 1)Study completedNCT03169959
What this trial is testing

Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 85
Not applicableUnknownNCT04226846
What this trial is testing

Feasibility Trial of the Bios Device for Continuous Glucose Monitoring

Who this might be right for
Type 1 DiabetesType 2 Diabetes
GraphWear Technologies Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00302224
What this trial is testing

A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
DiObex 50
Next Page